These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials. DeVincenzo JP Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462 [TBL] [Abstract][Full Text] [Related]
3. Prospects for the potential of RNA interference in the treatment of autoimmune diseases: Small interfering RNAs in the spotlight. Gorabi AM; Kiaie N; Aslani S; Jamialahmadi T; Johnston TP; Sahebkar A J Autoimmun; 2020 Nov; 114():102529. PubMed ID: 32782117 [TBL] [Abstract][Full Text] [Related]
4. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses. DeVincenzo JP Antivir Ther; 2012; 17(1 Pt B):213-25. PubMed ID: 22311654 [TBL] [Abstract][Full Text] [Related]
5. Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics. Akhtari J; Tafazoli A; Mehrad-Majd H; Mahrooz A Curr Clin Pharmacol; 2018; 13(3):173-182. PubMed ID: 29992895 [TBL] [Abstract][Full Text] [Related]
6. Current issues of RNAi therapeutics delivery and development. Haussecker D J Control Release; 2014 Dec; 195():49-54. PubMed ID: 25111131 [TBL] [Abstract][Full Text] [Related]
7. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy. Takahashi Y; Nishikawa M; Takakura Y Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274 [TBL] [Abstract][Full Text] [Related]
8. RNA interference-based therapy and its delivery systems. Chen X; Mangala LS; Rodriguez-Aguayo C; Kong X; Lopez-Berestein G; Sood AK Cancer Metastasis Rev; 2018 Mar; 37(1):107-124. PubMed ID: 29243000 [TBL] [Abstract][Full Text] [Related]
9. RNA interference silencing the transcriptional message: aspects and applications. Karkare S; Daniel S; Bhatnagar D Appl Biochem Biotechnol; 2004 Oct; 119(1):1-12. PubMed ID: 15496724 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers. Karim ME; Tha KK; Othman I; Borhan Uddin M; Chowdhury EH Pharmaceutics; 2018 May; 10(2):. PubMed ID: 29861465 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620 [TBL] [Abstract][Full Text] [Related]
14. RNA interference and its current application in mammals. Shen WG Chin Med J (Engl); 2004 Jul; 117(7):1084-91. PubMed ID: 15265387 [TBL] [Abstract][Full Text] [Related]
15. Exploring RNAi as a therapeutic strategy for controlling disease in aquaculture. Lima PC; Harris JO; Cook M Fish Shellfish Immunol; 2013 Mar; 34(3):729-43. PubMed ID: 23276883 [TBL] [Abstract][Full Text] [Related]
16. Current progress of siRNA/shRNA therapeutics in clinical trials. Burnett JC; Rossi JJ; Tiemann K Biotechnol J; 2011 Sep; 6(9):1130-46. PubMed ID: 21744502 [TBL] [Abstract][Full Text] [Related]